These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30480806)

  • 1. c-Met inhibition is required for the celecoxib-attenuated stemness property of human colorectal cancer cells.
    Lin YM; Lu CC; Hsiang YP; Pi SC; Chen CI; Cheng KC; Pan HL; Chien PH; Chen YJ
    J Cell Physiol; 2019 Jul; 234(7):10336-10344. PubMed ID: 30480806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
    Volpato M; Ingram N; Perry SL; Spencer J; Race AD; Marshall C; Hutchinson JM; Nicolaou A; Loadman PM; Coletta PL; Hull MA
    Cancer Chemother Pharmacol; 2021 Feb; 87(2):173-184. PubMed ID: 33040178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsteroidal anti-inflammatory drugs suppress cancer stem cells via inhibiting PTGS2 (cyclooxygenase 2) and NOTCH/HES1 and activating PPARG in colorectal cancer.
    Moon CM; Kwon JH; Kim JS; Oh SH; Jin Lee K; Park JJ; Pil Hong S; Cheon JH; Kim TI; Kim WH
    Int J Cancer; 2014 Feb; 134(3):519-29. PubMed ID: 23852449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous inhibition of EGFR/VEGFR and cyclooxygenase-2 targets stemness-related pathways in colorectal cancer cells.
    Valverde A; Peñarando J; Cañas A; López-Sánchez LM; Conde F; Hernández V; Peralbo E; López-Pedrera C; de la Haba-Rodríguez J; Aranda E; Rodríguez-Ariza A
    PLoS One; 2015; 10(6):e0131363. PubMed ID: 26107817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX-2 inhibition and colorectal cancer.
    Koehne CH; Dubois RN
    Semin Oncol; 2004 Apr; 31(2 Suppl 7):12-21. PubMed ID: 15252926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-Body PET Imaging in Humans Shows That
    Kim MJ; Anaya FJ; Manly LS; Lee JH; Hong J; Shrestha S; Telu S; Henry K; Santamaria JAM; Liow JS; Zanotti-Fregonara P; Shetty HU; Zoghbi SS; Pike VW; Innis RB
    J Nucl Med; 2023 Jan; 64(1):159-164. PubMed ID: 35798558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2-dependent and independent effects of COX-2 inhibitors and NSAIDs on proatherogenic changes in human monocytes/macrophages.
    Voloshyna I; Kasselman LJ; Carsons SE; Littlefield MJ; Gomolin IH; De Leon J; Reiss AB
    J Investig Med; 2017 Mar; 65(3):694-704. PubMed ID: 27940550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
    Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 inhibition inhibits c-Met kinase activity and Wnt activity in colon cancer.
    Tuynman JB; Vermeulen L; Boon EM; Kemper K; Zwinderman AH; Peppelenbosch MP; Richel DJ
    Cancer Res; 2008 Feb; 68(4):1213-20. PubMed ID: 18281498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSP90 inhibitor enhances anti-proliferative and apoptotic effects of celecoxib on HT-29 colorectal cancer cells via increasing BAX/BCL-2 ratio.
    Mohammadi A; Yaghoobi MM; GholamhoseynianNajar A; Kalantari-Khandani B; Sharifi H; Saravani M
    Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):62-67. PubMed ID: 27894402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells.
    Qorri B; Harless W; Szewczuk MR
    Drug Des Devel Ther; 2020; 14():4149-4167. PubMed ID: 33116404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celecoxib inhibits osteoblast differentiation independent of cyclooxygenase activity.
    Matsuyama A; Higashi S; Tanizaki S; Morotomi T; Washio A; Ohsumi T; Kitamura C; Takeuchi H
    Clin Exp Pharmacol Physiol; 2018 Jan; 45(1):75-83. PubMed ID: 28815657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.
    Yao M; Kargman S; Lam EC; Kelly CR; Zheng Y; Luk P; Kwong E; Evans JF; Wolfe MM
    Cancer Res; 2003 Feb; 63(3):586-92. PubMed ID: 12566300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut-Restricted Selective Cyclooxygenase-2 (COX-2) Inhibitors for Chemoprevention of Colorectal Cancer.
    Zhang Z; Ghosh A; Connolly PJ; King P; Wilde T; Wang J; Dong Y; Li X; Liao D; Chen H; Tian G; Suarez J; Bonnette WG; Pande V; Diloreto KA; Shi Y; Patel S; Pietrak B; Szewczuk L; Sensenhauser C; Dallas S; Edwards JP; Bachman KE; Evans DC
    J Med Chem; 2021 Aug; 64(15):11570-11596. PubMed ID: 34279934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of the drug response to nonsteroidal anti-inflammatory drugs according to cyclooxygenase-2 genetic polymorphism.
    Lee SJ; Park MK; Shin DS; Chun MH
    Drug Des Devel Ther; 2017; 11():2727-2736. PubMed ID: 29066864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies.
    Madhava G; Ramana KV; Sudhana SM; Rao DS; Kumar KH; Lokanatha V; Rani AU; Raju CN
    Med Chem; 2017; 13(5):484-497. PubMed ID: 28228088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and Metabolomic Investigation of Celecoxib Antiproliferative Activity in Mono-and Combination Therapy against Breast Cancer Cell Models.
    Bardaweel SK; Dahabiyeh LA; Akileh BM; Shalabi DD; AlHiary AK; Pawling J; Dennis JW; Rahman AMA
    Anticancer Agents Med Chem; 2022; 22(8):1611-1621. PubMed ID: 34515014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Celecoxib as a Potential Inhibitor in the Treatment of Inflammatory Diseases - A Review.
    Cruz JV; Rosa JMC; Kimani NM; Giuliatti S; Dos Santos CBR
    Curr Med Chem; 2022; 29(17):3028-3049. PubMed ID: 34514981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2.
    Wallace JL; McKnight W; Reuter BK; Vergnolle N
    Gastroenterology; 2000 Sep; 119(3):706-14. PubMed ID: 10982765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.